Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Recall 2026
BioSpectra, Inc.Issued July 29, 2026Updated Reviewed by the Recall Watch editorial team
BioSpectra, Inc. Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25 — recalled per FDA on 7/29/2026. Reason: Failed stability specifications.
- Agency
- FDA
- Issued
- Jul 29, 2026
- Brand
- BioSpectra, Inc.
- Distribution
- 1 states
- Lots affected
- 2
Steps to take for this recall
Stop using it
Take it out of rotation. Don't consume, wear, or operate.
Verify the match
Compare lot numbers, UPCs, and dates against your product.
Return or dispose
Follow the manufacturer's instructions to refund or safely dispose.
Free case review
Were you or someone in your household prescribed this medication?
- Free
- No obligation
- Licensed attorneys
Attorney advertising.DetailsHide
Recall Watch is not a law firm and does not provide legal or medical advice. Free case reviews are provided by independent licensed attorneys; Recall Watch may receive a referral fee. Prior results do not guarantee a similar outcome. Submitting this form does not create an attorney-client relationship. See our terms and privacy policy.
What's recalled
Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25

Restock your medicine cabinet
First-aid kits, thermometers and OTC basics, searched on Amazon.
Need it delivered? Start a free Amazon Prime trial.
Why it was recalled
Failed stability specifications
Affected products & lot numbers2 lots called out
Affected Lot Numbers
Check your product label — do not use if your lot number appears below.
| Lot Number |
|---|
| Lot#: TRIS -E04-0226-0016 |
| Exp 2/29/28 |
Where was it sold1 state
CA
More recalls like this4 related — by brand, contaminant, and category
Recent Medications recalls
- Wedgewood Pharmacy Certain Compounded Veterinary Medications Within Expiry Recall 20262026
- Par Health Issues Voluntary Nationwide Argatroban Injection Recall 20262026
- Par Pharmaceutical Par Health Issues Voluntary Nationwide Two Lots Recall 20262026
Frequently asked questions
Is the BioSpectra, Inc. recall still active?
Yes, this recall is currently active as of July 29, 2026. Do not use or consume the affected product.
What lot numbers are affected?
Affected lot numbers: Lot#: TRIS -E04-0226-0016, Exp 2/29/28. Check the label on your product.
What should I do if I have the recalled BioSpectra, Inc.?
Do not consume or use this product. Return it to the store for a full refund, or dispose of it safely.